Ligand validation:3FF3

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3FF3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3FF3_NAG_A_1756	48%	55%	0.181	0.924	0.73	0.99	-	-	1	0	100%	0.9333
3FF3_NAG_A_1758	29%	58%	0.159	0.818	0.61	1	-	1	1	0	100%	0.9333
3FF3_NAG_A_1757	4%	29%	0.322	0.697	0.55	2.26	-	6	0	0	100%	0.9333
3FED_NAG_A_1758	54%	48%	0.128	0.892	0.69	1.29	-	3	0	0	100%	0.9333
3FEE_NAG_A_1756	36%	50%	0.199	0.894	0.67	1.24	-	3	1	0	100%	0.9333
3FEC_NAG_A_1756	22%	41%	0.216	0.835	0.63	1.65	-	4	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_A_601	100%	70%	0.024	0.993	0.3	0.85	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.